Skip to main content

Table 1 Patient characteristics

From: High frequency of corticosteroid and immunosuppressive therapy in patients with systemic sclerosis despite limited evidence for efficacy

  Total Missing data Limited cutaneous systemic sclerosis Diffuse cutaneous systemic sclerosis Overlap syndrome
Characteristic
   Number of patients (n (%)) 1,419 (100%) 0.9 56 (53.4%) 492 (34.7%) 168 (11.9%)
   Female 82.8 0.1 88.0 74.9 85.1
   Male 17.2 0.1 12.0 25.1 14.9
   Antinuclear antibodies (ANA)-positive 91.5 0.5 89.9 91.9 95.8
   Scl 70-positive 30.9 0.7 18.5 55.6 11.4
   Anticentromere antibodies (ACA)-positive 36.6 2.5 59.7 10.2 16.2
Organ involvement by systemic sclerosis subset
   Raynaud phenomenon 95.8 0.2 96.3 95.1 96.4
   Skin involvement 93.5 0.4 92.8 97.5 83.9
   Pulmonary hypertension 14.2 0.4 12.8 17.7 9.5
   Pulmonary fibrosis 38.0 0.4 24.6 59.1 33.3
   Esophagus 63.6 0.3 61.1 67.4 64.9
   Stomach 15.2 0.5 15.8 14.5 14.9
   Intestine 5.7 0.5 6.3 5.1 5.4
   Kidney 12.3 0.5 10.3 16.1 7.1
   Heart 14.9 0.5 11.2 21.2 11.3
   Musculoskeletal system 51.0 8.1 45.1 53.7 68.3
   Nervous system 6.2 1.8 5.7 5.6 10.1
   Sicca symptoms 42.0 2.3 45.5 36.9 43.4
   Masticatory organ 30.3 12.4 25.3 38.6 27.5
  1. Data presented as percentages unless stated otherwise.